Logo image of FAMI

FARMMI INC (FAMI) Stock Fundamental Analysis

NASDAQ:FAMI - Nasdaq - KYG332771313 - Common Stock - Currency: USD

0.2424  -0.01 (-2.53%)

Fundamental Rating

3

Taking everything into account, FAMI scores 3 out of 10 in our fundamental rating. FAMI was compared to 90 industry peers in the Food Products industry. While FAMI seems to be doing ok healthwise, there are quite some concerns on its profitability. FAMI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

FAMI had positive earnings in the past year.
In the past year FAMI has reported a negative cash flow from operations.
Of the past 5 years FAMI 4 years were profitable.
In the past 5 years FAMI reported 4 times negative operating cash flow.
FAMI Yearly Net Income VS EBIT VS OCF VS FCFFAMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M -60M

1.2 Ratios

FAMI has a Return On Assets of 0.93%. This is in the lower half of the industry: FAMI underperforms 61.18% of its industry peers.
FAMI has a worse Return On Equity (0.97%) than 60.00% of its industry peers.
FAMI's Return On Invested Capital of 1.20% is on the low side compared to the rest of the industry. FAMI is outperformed by 63.53% of its industry peers.
The Average Return On Invested Capital over the past 3 years for FAMI is significantly below the industry average of 9.06%.
The last Return On Invested Capital (1.20%) for FAMI is above the 3 year average (1.04%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.93%
ROE 0.97%
ROIC 1.2%
ROA(3y)1.41%
ROA(5y)1.07%
ROE(3y)1.49%
ROE(5y)1.19%
ROIC(3y)1.04%
ROIC(5y)3.79%
FAMI Yearly ROA, ROE, ROICFAMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

1.3 Margins

FAMI has a Profit Margin of 1.85%. This is comparable to the rest of the industry: FAMI outperforms 42.35% of its industry peers.
In the last couple of years the Profit Margin of FAMI has declined.
FAMI has a Operating Margin (2.67%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of FAMI has declined.
FAMI has a Gross Margin of 4.95%. This is amonst the worse of the industry: FAMI underperforms 88.24% of its industry peers.
In the last couple of years the Gross Margin of FAMI has declined.
Industry RankSector Rank
OM 2.67%
PM (TTM) 1.85%
GM 4.95%
OM growth 3Y-38.63%
OM growth 5Y-29.11%
PM growth 3Y-7.28%
PM growth 5Y-26.57%
GM growth 3Y-38.12%
GM growth 5Y-25.57%
FAMI Yearly Profit, Operating, Gross MarginsFAMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

5

2. Health

2.1 Basic Checks

FAMI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for FAMI has been increased compared to 1 year ago.
Compared to 5 years ago, FAMI has more shares outstanding
The debt/assets ratio for FAMI is higher compared to a year ago.
FAMI Yearly Shares OutstandingFAMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
FAMI Yearly Total Debt VS Total AssetsFAMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

An Altman-Z score of 1.95 indicates that FAMI is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of FAMI (1.95) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.04 indicates that FAMI is not too dependend on debt financing.
FAMI has a Debt to Equity ratio of 0.04. This is in the better half of the industry: FAMI outperforms 78.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 1.95
ROIC/WACC0.26
WACC4.57%
FAMI Yearly LT Debt VS Equity VS FCFFAMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 21.81 indicates that FAMI has no problem at all paying its short term obligations.
FAMI's Current ratio of 21.81 is amongst the best of the industry. FAMI outperforms 100.00% of its industry peers.
A Quick Ratio of 17.55 indicates that FAMI has no problem at all paying its short term obligations.
The Quick ratio of FAMI (17.55) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 21.81
Quick Ratio 17.55
FAMI Yearly Current Assets VS Current LiabilitesFAMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2

3. Growth

3.1 Past

FAMI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.80%.
Measured over the past years, FAMI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -64.54% on average per year.
FAMI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.67%.
Measured over the past years, FAMI shows a very strong growth in Revenue. The Revenue has been growing by 29.92% on average per year.
EPS 1Y (TTM)-89.8%
EPS 3Y-69.15%
EPS 5Y-64.54%
EPS Q2Q%-84.78%
Revenue 1Y (TTM)-26.67%
Revenue growth 3Y57.29%
Revenue growth 5Y29.92%
Sales Q2Q%-39.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FAMI Yearly Revenue VS EstimatesFAMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
FAMI Yearly EPS VS EstimatesFAMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 1.86 indicates a rather cheap valuation of FAMI.
Based on the Price/Earnings ratio, FAMI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
FAMI is valuated cheaply when we compare the Price/Earnings ratio to 28.47, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 1.86
Fwd PE N/A
FAMI Price Earnings VS Forward Price EarningsFAMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FAMI is valued cheaper than 98.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.66
FAMI Per share dataFAMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FAMI!.
Industry RankSector Rank
Dividend Yield N/A

FARMMI INC

NASDAQ:FAMI (2/5/2025, 12:49:06 PM)

0.2424

-0.01 (-2.53%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-22 2022-08-22/bmo
Earnings (Next)N/A N/A
Inst Owners0.77%
Inst Owner Change0%
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap2.59M
Analysts0
Price TargetN/A
Short Float %15.26%
Short Ratio0.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.86
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.02
P/tB 0.02
EV/EBITDA 0.66
EPS(TTM)0.13
EY53.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.43
FCFYN/A
OCF(TTM)-7.43
OCFYN/A
SpS8.08
BVpS15.39
TBVpS15.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.93%
ROE 0.97%
ROCE 1.4%
ROIC 1.2%
ROICexc 1.21%
ROICexgc 1.21%
OM 2.67%
PM (TTM) 1.85%
GM 4.95%
FCFM N/A
ROA(3y)1.41%
ROA(5y)1.07%
ROE(3y)1.49%
ROE(5y)1.19%
ROIC(3y)1.04%
ROIC(5y)3.79%
ROICexc(3y)1.43%
ROICexc(5y)4.05%
ROICexgc(3y)1.43%
ROICexgc(5y)4.05%
ROCE(3y)1.2%
ROCE(5y)4.94%
ROICexcg growth 3Y-42.06%
ROICexcg growth 5Y-41.49%
ROICexc growth 3Y-42%
ROICexc growth 5Y-41.49%
OM growth 3Y-38.63%
OM growth 5Y-29.11%
PM growth 3Y-7.28%
PM growth 5Y-26.57%
GM growth 3Y-38.12%
GM growth 5Y-25.57%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 2.54
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 14.47
Cash Conversion N/A
Profit Quality N/A
Current Ratio 21.81
Quick Ratio 17.55
Altman-Z 1.95
F-Score4
WACC4.57%
ROIC/WACC0.26
Cap/Depr(3y)5.15%
Cap/Depr(5y)101.59%
Cap/Sales(3y)0.01%
Cap/Sales(5y)0.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.8%
EPS 3Y-69.15%
EPS 5Y-64.54%
EPS Q2Q%-84.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.67%
Revenue growth 3Y57.29%
Revenue growth 5Y29.92%
Sales Q2Q%-39.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.72%
EBIT growth 3Y-3.48%
EBIT growth 5Y-7.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.03%
OCF growth 3YN/A
OCF growth 5YN/A